Navigation Links
Avanir Pharmaceuticals to Present at Three Conferences in March
Date:2/23/2011

ALISO VIEJO, Calif., Feb. 23, 2011 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (Nasdaq: AVNR) today announced that company management will present an overview of the company at the following conferences in March.

  • Citi 2011 Global Healthcare Conference
    • Location: Hilton New York, New York, NY
    • Presentation date: Tuesday March 1, 2011
    • Presentation time: 8:00am ET

  • Cowen & Company Healthcare Conference
    • Location: Boston Marriott, Boston, MA
    • Presentation date: Tuesday March 8, 2011
    • Presentation time: 8:45am ET

  • 2011 Roth OC Growth Conference
    • Location: The Ritz Carlton, Laguna Niguel, CA
    • Presentation date: Monday March 14, 2011
    • Presentation time: 5:00pm PT

A live webcast and 30-day archive of these presentations will be available at http://www.avanir.com.

About Avanir Pharmaceuticals, Inc.

Avanir Pharmaceuticals, Inc. is a biopharmaceutical company focused on bringing innovative medicines to patients with central nervous system disorders of high unmet medical need. As part of our commitment, we have extensively invested in our pipeline and are dedicated to advancing medicines that can substantially improve the lives of patients and their loved ones. For more information about Avanir, please visit www.avanir.com.

AVANIR™ and NUEDEXTA™ are trademarks owned by Avanir Pharmaceuticals, Inc.

©2011 Avanir Pharmaceuticals, Inc. All Rights Reserved.


'/>"/>
SOURCE Avanir Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. AVANIR Pharmaceuticals Invites Investors to Fiscal 2010 Third Quarter Conference Call
2. AVANIR Pharmaceuticals to Present at the UBS Global Life Sciences Conference
3. AVANIR Pharmaceuticals Announces FDA Approval of NUEDEXTA™
4. AVANIR Pharmaceuticals Invites Investors to Conference Call Regarding FDA Approval of NUEDEXTA™ on Monday November 1, 2010
5. AVANIR Pharmaceuticals Announces Pricing of Public Offering of Common Stock
6. AVANIR Pharmaceuticals Announces NASDAQ Opening Bell Ceremony
7. AVANIR Pharmaceuticals Invites Investors to Fiscal 2011 First Quarter Conference Call
8. AVANIR Pharmaceuticals Announces Fiscal 2011 First Quarter Financial Results
9. AVANIR Pharmaceuticals Appoints Gregory J. Flesher to Senior Vice President and Chief Business Officer
10. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
11. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... Research and Markets has announced the addition ... Industry Forecast to 2025" report to their offering. ... The Global Pharmaceutical Packaging ... over the next decade to reach approximately $129.81 billion by 2025. ... for all the given segments on global as well as regional ...
(Date:3/22/2017)... -- Piramal Pharma Solutions (PPS), a leading ... event to introduce the new and expanded manufacturing capabilities ... . The inaugural event was attended by Governor ... and Piramal Pharma Solutions CEO, Vivek Sharma . ... ...
(Date:3/22/2017)... Mass. , March 22, 2017 Hologic, ... it has completed the acquisition of Cynosure, Inc., a ... per share in cash. "We are pleased ... to working with Michael Davin and the ... the large, rapidly growing medical aesthetics market," said ...
Breaking Medicine Technology:
(Date:3/22/2017)... ... March 22, 2017 , ... The ... PCSK9 inhibitor prior authorization (PA) form for prescribers to improve patients’ access to ... the helpful tools published as part of the article entitled “PCSK9 Inhibitor ...
(Date:3/22/2017)... ... March 22, 2017 , ... Donor Network ... Nevada and LABS, Inc., announced the future opening of a CLIA certified dedicated ... serology testing used to determine the suitability of potential organ and tissue ...
(Date:3/22/2017)... Birmingham, Ala. (PRWEB) , ... March 22, 2017 ... ... consumer experience solution provider, today announced that its digital marketing solutions have enabled ... their marketing investment in 24 months. , Recognizing the value of a ...
(Date:3/22/2017)... ... March 22, 2017 , ... Drs. Jennifer Houck, Lauren Smith, Heather Johnson ... new patients in need of skilled pediatric dentistry in Rock Hill, SC, ... pediatric patients routine treatments, including cavities, sealants and fluoride applications, in a comfortable and ...
(Date:3/22/2017)... ... ... Last year, 43 million gallons of surplus milk was reportedly dumped by ... dairy can be caused by several factors, one pharmaceutical company CEO suggests high rates ... lactose, a sugar found in milk and milk products. It is estimated ...
Breaking Medicine News(10 mins):